Focus on Healthcare & Biotechnology Investor Relations
Stern IR is the premier investor relations firm focusing on the entrepreneurial healthcare and biotechnology industries.
We have comprehensive, up-to-the-minute knowledge of the technical, regulatory and financial aspects of this very dynamic industry. We closely monitor industry trends to provide a comprehensive, data-driven approach to investor relations counsel.
We keep up to date on the frequent changes in the financial markets and the healthcare and biotechnology industries, and harness that knowledge to create personalized communications strategies. In addition, our clients’ needs change also: Stern IR recognizes the importance of routinely re-evaluating each client’s IR program to address evolving corporate needs and the macro environment, in order to ensure maximum impact from the IR program.
We have longstanding and personal relationships with our clients and tailor each IR program to each client’s specific needs and goals. We are committed to superior client service and are dedicated to providing senior level attention, strategic counsel and critical, disciplined tactical support.